Bristol Myers Squibb (CELG-RI) Income from Non-Controlling Interests (2009 - 2026)

Bristol Myers Squibb (CELG-RI) has reported Income from Non-Controlling Interests for 18 consecutive years, with -$1.0 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Income from Non-Controlling Interests fell 150.0% year-over-year to -$1.0 million; the TTM figure through Jun 2026 stood at -$7.0 million (down 143.75% YoY), while the FY2025 annual figure was $2.0 million, down 86.67% from the prior year.
• Income from Non-Controlling Interests eased to -$1.0 million in Q2 2026 per CELG-RI's latest filing, from $1.0 million in the prior quarter.
• Across five years, Income from Non-Controlling Interests topped out at $8.0 million in Q2 2022 and bottomed at -$6.0 million in Q3 2025.
• Historically, Income from Non-Controlling Interests has averaged $2.9 million across 5 years, with a median of $4.0 million in 2023.
• Annual changes were most pronounced in 2023 — Income from Non-Controlling Interests jumped 200.0% — and 2025, when it sank 250.0%.
• Bristol Myers Squibb's Income from Non-Controlling Interests stood at $3.0 million in 2022, then surged by 100.0% to $6.0 million in 2023, then plunged by 33.33% to $4.0 million in 2024, then tumbled by 125.0% to -$1.0 million in 2025, then changed by 0.0% to -$1.0 million in 2026.
• Business Quant data shows CELG-RI's Income from Non-Controlling Interests at -$1.0 million in Q2 2026, $1.0 million in Q1 2026, and -$1.0 million in Q4 2025.